Skip to content

Azenta AZTA Total Current Liabilities

Total Current Liabilities at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$14.62B+11.0%
Danaher logo
DanaherDHR
$7.46B+12.3%
Labcorp Holdings logo
Labcorp HoldingsLH
$2.64B+27.9%
Illumina logo
IlluminaILMN
$1.57B+8.8%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$224.87M+204%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$119.98M+60.0%

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-19.0%
Enterprise value$1.03B
P/S1.8×-0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's total current liabilities?
Azenta (AZTA) reported total current liabilities of $257.19M in Q1 2026.
What is the long-term trend for Azenta's total current liabilities?
Over 4 years (2020 to 2025), Azenta's total current liabilities has grown at a 3.0% compound annual growth rate (CAGR), from $211.12M to $237.67M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.